SCHEMBL3056007

SCHEMBL3056007

CCc1noc(C2CCCN(c3nncc4c(OC)c(OC)c(OC)cc34)C2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.39
TSHR P16473 2/20 0.38
EPHA2 P29317 2/20 0.38
EPHB4 P54760 2/20 0.38
ERBB2 P04626 1/20 0.38
PDE3A Q14432 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ATM Q13315 1/20 0.37
KDR P35968 1/20 0.37
RECQL P46063 1/20 0.36
PRKDC P78527 1/20 0.35
MTOR P42345 1/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
PDE10A Q9Y233 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057287 0.89 HTT (0.39) ALDH1A1LMNAEPHA2EPHB4ERBB2
SCHEMBL3057233 0.88 PDE10A (0.46) ALDH1A1LMNATSHREPHA2EPHB4
SCHEMBL3047030 0.88 PRKDC (0.46) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3053157 0.86 ALDH1A1 (0.43) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3055966 0.82 PDE3A (0.41) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3059655 0.81 MAP4K4 (0.41) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3056642 0.81 PDE3A (0.40) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3059863 0.80 PDE3A (0.38) ALDH1A1LMNAHPGDTSHRPDE3A
SCHEMBL3059818 0.78 PRKDC (0.49) ALDH1A1LMNATSHRPDE3APRKDC
SCHEMBL3056060 0.78 PDE3A (0.37) ALDH1A1LMNAHPGDPDE3APRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-09-02 US claimed
EP-1981868-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS Pfizer Products Inc. (US) 2008-10-22 EP claimed
WO-2007085954-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2007-08-02 WO claimed
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-09-02 US disclosed
EP-1981868-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS Pfizer Products Inc. (US) 2008-10-22 EP disclosed
WO-2007085954-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PDE12, PDE5A, PDE2A ALDH1A1 997/4885LMNA 4217/4885HPGD 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.